Literature DB >> 11048284

[Psychosocial aspects of beta-thalassemia: distress, coping and adherence].

L Goldbeck1, A Baving, E Kohne.   

Abstract

BACKGROUND: Longtime outcome in case of thalassemia depends on the patients' adherence in home treatment to reduce hemosiderosis. This study describes the patients' perspective, their typical coping strategies, health related locus-of-control-beliefs and psychosocial influences on adherence. PATIENTS AND METHODS: A battery of questionnaires was employed to 43 patients with thalassemia major (3 to 26 years old) treated in Germany according to the german multicenter study respectively their parents: the Ulm Thalassemia Inventory, the KIDCOPE, the Multidimensional Health Locus of Control Scales and the Giessen Complaint List. Clinical symptoms of hemosiderosis were correlated with psychosocial variables.
RESULTS: The patients feel more distressed from their treatment than from their illness itself. They react to disease-related distress with a variety of coping strategies. Some of the most frequent coping strategies are maladaptive, indicating feelings of helplessness. Internal locus-of-control-beliefs were low and fatalistic locus-of-control-beliefs were high compared with other clinical groups. The self-reported adherence to the iron chelation treatment is correlated with age, gender, age at the start-point of the treatment and emotional distress. Complaints, coping strategies and locus of control are independent from adherence as well as from hemosiderosis.
CONCLUSION: Patients with thalassemia major need more information about their disease and about the benefits of iron chelation therapy. Additional psychosocial support should reduce emotional distress, strengthen coping competence and lead to a better integration of therapy in daily life.

Entities:  

Mesh:

Year:  2000        PMID: 11048284     DOI: 10.1055/s-2000-9683

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  8 in total

1.  Neurotic manifestations in adolescents with thalassemia major.

Authors:  J D Moorjani; Chithira Issac
Journal:  Indian J Pediatr       Date:  2006-07       Impact factor: 1.967

2.  Iron chelation adherence to deferoxamine and deferasirox in thalassemia.

Authors:  Felicia Trachtenberg; Elliott Vichinsky; Dru Haines; Zahra Pakbaz; Lauren Mednick; Amy Sobota; Janet Kwiatkowski; Alexis A Thompson; John Porter; Thomas Coates; Patricia J Giardina; Nancy Olivieri; Robert Yamashita; Ellis J Neufeld
Journal:  Am J Hematol       Date:  2011-05       Impact factor: 10.047

3.  Pregnant women affected by thalassemia major: a controlled study of traits and personality.

Authors:  Giuseppina Messina; Elisa Colombo; Elena Cassinerio; Claudia Cesaretti; Alessia Marcon; Laura Zanaboni; Marina Baldini; Maria Domenica Cappellini
Journal:  J Res Med Sci       Date:  2010-03       Impact factor: 1.852

4.  Evaluation of Mental Health and Related Factors among Patients with Beta-thalassemia Major in South East of Iran.

Authors:  Majid Naderi; Mohammad Reza Hormozi; Morteza Ashrafi; Abolfazl Emamdadi
Journal:  Iran J Psychiatry       Date:  2012

5.  Health Related Quality of Life in Malaysian children with thalassaemia.

Authors:  Adriana Ismail; Michael J Campbell; Hishamshah Mohd Ibrahim; Georgina L Jones
Journal:  Health Qual Life Outcomes       Date:  2006-07-02       Impact factor: 3.186

6.  An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use.

Authors:  Alexandra Ward; J Jaime Caro; Traci Craig Green; Krista Huybrechts; Alejandro Arana; Suzanne Wait; Androulla Eleftheriou
Journal:  BMC Clin Pharmacol       Date:  2002-04-23

7.  Emotional impact in beta-thalassaemia major children following cognitive-behavioural family therapy and quality of life of caregiving mothers.

Authors:  Luigi Mazzone; Laura Battaglia; Francesca Andreozzi; Maria Antonietta Romeo; Domenico Mazzone
Journal:  Clin Pract Epidemiol Ment Health       Date:  2009-02-23

8.  Health-related quality of life in pediatric and adolescent patients with transfusion-dependent ß-thalassemia in upper Egypt (single center study).

Authors:  Gehan L Abdel Hakeem; Suzan O Mousa; Asmaa N Moustafa; Mohamed H Mahgoob; Ebtesam E Hassan
Journal:  Health Qual Life Outcomes       Date:  2018-04-10       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.